| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 221.14B | 232.20B | 214.13B | 192.99B | 176.92B | 168.53B |
| Gross Profit | 53.61B | 55.91B | 48.98B | 43.26B | 41.47B | 40.46B |
| EBITDA | 10.74B | 10.66B | 10.27B | 9.67B | 7.57B | 9.45B |
| Net Income | 5.15B | 4.77B | 4.94B | 5.17B | 3.82B | 5.25B |
Balance Sheet | ||||||
| Total Assets | 71.38B | 81.56B | 71.35B | 61.87B | 58.06B | 54.53B |
| Cash, Cash Equivalents and Short-Term Investments | 16.45B | 20.79B | 16.87B | 17.14B | 15.69B | 17.03B |
| Total Debt | 15.42B | 20.31B | 14.08B | 9.21B | 9.34B | 9.36B |
| Total Liabilities | 38.50B | 46.03B | 38.77B | 31.90B | 31.30B | 29.78B |
| Stockholders Equity | 32.88B | 35.52B | 32.57B | 29.97B | 26.76B | 24.59B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 2.63B | 3.72B | 3.52B | 1.29B | 2.76B |
| Operating Cash Flow | 0.00 | 7.07B | 7.51B | 7.39B | 3.96B | 5.63B |
| Investing Cash Flow | 0.00 | -7.32B | -8.84B | -4.00B | -3.31B | -3.22B |
| Financing Cash Flow | 0.00 | 4.16B | 999.00M | -1.94B | -2.00B | -1.64B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | ¥101.20B | 9.97 | ― | 1.92% | 2.00% | 9.17% | |
71 Outperform | ¥81.20B | 9.00 | ― | 1.47% | 7.10% | 0.95% | |
69 Neutral | ¥217.59B | 23.19 | ― | 2.43% | 3.62% | 11.00% | |
69 Neutral | ¥130.83B | 10.30 | ― | 1.64% | 9.19% | 2.45% | |
66 Neutral | ¥59.32B | 12.38 | ― | 2.85% | 8.44% | -3.33% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
62 Neutral | ¥53.72B | 9.24 | ― | 1.34% | 21.78% | 12.45% |